english.prescrire.org > Spotlight > Archives : 2026 > In-utero exposure to PD-1 and PD-L1 inhibitors: autoimmune disorders?

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2026 : 1 | 30

In-utero exposure to PD-1 and PD-L1 inhibitors: autoimmune disorders?

 Adverse Effects  Several cases of autoimmune disorders have been reported in children exposed in utero to an immunostimulant of the PD-1 immune checkpoint inhibitor class.
Full article available for download by subscribers

 ©Prescrire 1 September 2026

Source: "In-utero exposure to PD-1 and PD-L1 inhibitors: autoimmune disorders?" Prescrire Int 2026; 35 (284): 213-214. Subscribers only.

Filet

Enjoy full access to Prescrire International, and support independent information